Clinical efficacy of percutaneous renal revascularization with stent placement in atherosclerotic renovascular disease;Eficácia clínica da revascularização renal percutânea com implante de stent em pacientes com doença renovascular aterosclerótica

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 1, 2007, Pages 76-80

  Gonçalves, Janaína Andréa Altemar ^a,b   Amorim, Jorge Eduardo ^a   Neto, Milton Macedo Soares ^a   Ribeiro, Artur Beltrame ^a   Lima, Valter Correa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Angioplasty; Renal artery; Renovascular hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; AGED; ANGIOPLASTY; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; RENOVASCULAR DISEASE; STENT; TREATMENT OUTCOME; KIDNEY ARTERY STENOSIS; MIDDLE AGED; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; RENOVASCULAR HYPERTENSION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ATHEROSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENOVASCULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL ARTERY OBSTRUCTION; STENTS; TREATMENT OUTCOME;

EID: 33947324202     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2007000100014     Document Type: Article

References (25)

1. Uzu T, Inoue T, Fujii T, Nakamura S, Inenaga T, Yutani C, et al. Prevalence and predictors or renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis. 1997; 29: 733-8.
2. Maiolloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: A 20-year clinical experience. Am J Kidney Dis. 1994; 24: 622-9.
3. Pohl MA, Kaplan N. Renal artery stenosis, renal vascular hypertension, and ischemic nephropathy. In: Schrier RW, Gottschalk CW (eds). Diseases of the kidney and urinary tract. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1399-457.
4. Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension. Arch Intern Med. 1987;147: 820-9.
5. Hansen KJ, Edwards MS, Craven, TE, Cherr GS, Jackson AS, Appel RG, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002; 36: 443-51.
6. Alcazar JM, Rodicio, JL. Ischemic nephropathy: clinical characteristics and treatment. Am J Kidney Dis. 2000; 36: 88-93.
7. Baboolal, K, Evans, C, Moore, RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis. 1998; 31: 971-7.
8. Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW, Cantwell-Gab K, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998; 53: 735-42.
9. Van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, et al. The effect of ballon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000; 342: 1007-14.
10. Textor SC, Wilcox CS. Renal artery stenosis: A commom, treatable cause or renal failure? Annu Rev Med. 2001; 52: 421-42.
11. Textor SC. Revascularization in atherosclerotic renal artery disease. Kidney Int. 1998; 53: 799-811.
12. IV Diretrizes Brasileiras de Hipertensão Arterial. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Nefrologia e Sociedade Brasileira de Hipertensão. Arq Bras Cardiol. 2004; 82 (supl. 4): 1.
13. Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006; 152: 59-66.
14. Chábová V, Schrirger A, Stanson AW, Mckusick MA, Textor SC.Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc. 2000; 75: 437-44.
15. Campo A, Boero R, Stratta P, Quarello F. Selective stenting and the course of atherosclerotic renovascular nephropathy. J Nephrol. 2002; 15: 525-9.
16. Tuttle KR, Raabe RD. Endovascular stents for renal artery revascularization. Curr Opin Nephrol Hypertens. 1998; 7: 695-701.
17. Leertouwer TC, Derkx FHM, Pattynama PM, Deinum J, van Dijk LC. Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int. 2002; 62: 574-9.
18. Ramos F, Kotliar C, Alvarez D, Baglivo H, Rafaelle P, Londero H, et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int. 2003; 63: 276-82.
19. Bakker J, Beutler JJ, Elgersma OE, de Lange EE, de Kort GA, Beek FJ, et al. Duplex ultrasonography in assessing restenosis of renal artery stents. Cardiovasc Intervent Radiol. 1999; 22: 475-80.
20. van de Ven PJ, Beutler JJ, Kaatee R, Beek FJ, Mali WP, Geysker GG, et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet. 1995; 346: 672-4.
21. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in tem studies. QJM. 1999; 92: 159-67.
22. Rees CR. Stents for atherosclerotic renovascular disease. J Vasc Interv Radiol. 1999; 10: 689-705.
23. Bloch MJ, Pickering TG: Renal vascular disease: medical management, angioplasty and stenting. Semin Nephrol. 2000; 20: 474-88.
24. Jensen G, Zachrisson BF, Delin K, Volkmann R, Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int. 1995; 48: 1936-45.
25. Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000; 102: 1671-7.